News|Articles|November 4, 2025

8 Cardiology Headlines You Missed in October 2025

Fact checked by: Tim Smith

Catch up with groundbreaking FDA decisions, exciting new GLP-1 news, and more.

Cardiology has expanded exponentially in October 2025, between critical new research on GLP-1 receptor agonists and key new approvals from the US Food and Drug Administration (FDA). Topline results from trials like Bax24 and iMODERN have opened potential new avenues for both investigation and, potentially, treatment of various cardiovascular diseases.